Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMay 18, 2016Ondansetron Tablets USPFailed Impurities/Degradation Specifications; 12 month stability time pointDr. Reddy's Laboratories, Inc. · D-0841-2016Class IITerminatedMay 18, 2016Paliperidone Extended-release TabletsFailed Dissolution Specifications; three month stability time point.Mylan Pharmaceuticals Inc. · D-0840-2016Class IIITerminatedMay 11, 2016Acetaminophen & Codeine Phosphate TabletsLabeling: Not elsewhere classified - count on the label was incorrect.A-S Medication Solutions LLC. · D-0839-2016Class IITerminatedMay 11, 2016Oxycodone Hydrochloride Oral SolutionDefective Container: Excess lidding material accumulation between the seal and the cup resulting in the lid not properly adhering and allowing leakage.VistaPharm, Inc. · D-0838-2016Class IIITerminatedMay 11, 2016Venlafaxine 75 mg TabletLabeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate...Bryant Ranch Prepack Inc. · D-0837-2016Class IIIOngoingMay 11, 2016QuelicinLabeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.Hospira Inc. · D-0836-2016Class IITerminatedMay 11, 2016Good Neighbor Pharmacy PEG-Phen Lubricant Eye DropsPresence of Particulate MatterAkorn, Inc. · D-0835-2016Class IIITerminatedMay 4, 2016SKY Aspirin Chewable TabletsLabeling: Label mix-up -outer carton incorrectly labeled as aspirin chewable tablets.Mckesson Packaging Services · D-0834-2016Class IIITerminatedApr 27, 2016ZemplarFailed Content Uniformity SpecificationsAbbVie Inc. · D-0833-2016Class IITerminatedApr 27, 2016Potassium Chloride Injection 20 mEqChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0832-2016Class IITerminatedApr 27, 2016Mannitol I.VChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0831-2016Class IITerminatedApr 27, 2016Aminosyn-PFChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0830-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0829-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0828-2016Class IITerminatedApr 27, 2016Dextrose InjectionChemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.Hospira Inc. · D-0827-2016Class IITerminatedApr 27, 2016Dextroamphetamine Sulfate Tablets USPFailed Impurities/Degradation SpecificationsImpax Laboratories, Inc. · D-0826-2016Class IITerminatedApr 27, 2016Dextroamphetamine Sulfate Tablets USPFailed Impurities/Degradation SpecificationsImpax Laboratories, Inc. · D-0825-2016Class IIITerminatedApr 27, 2016Telmisartan TabletsPresence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.Torrent Pharmaceuticals Limited · D-0824-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp DateAmerisource Health Services · D-0823-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp DateAmerisource Health Services · D-0822-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp. DateImpax Laboratories, Inc. · D-0821-2016Class IIITerminatedApr 20, 2016Fenofibrate CapsulesLabeling: Incorrect or Missing Lot and/or Exp. DateImpax Laboratories, Inc. · D-0820-2016Class IITerminatedApr 20, 2016Cisatracurium Besylate InjectionIncorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer...Fresenius Kabi USA, LLC · D-0819-2016Class IIITerminatedApr 20, 2016Haloperidol Decanoate InjectionFailed Impurities/Degradation Specifications: Firm is recalling product due to an impurity out-of-specification result.Fresenius Kabi USA, LLC · D-0818-2016Class IIITerminatedApr 20, 2016Simvastatin TabletsSubpotent DrugBiocon Inc · D-0817-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0816-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0815-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0814-2016Class IITerminatedApr 13, 2016Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications: Out of specification for impurities.Actavis Elizabeth LLC · D-0813-2016Class IIITerminatedApr 13, 2016SODIUM IODIDE I 131 CAPSULELabeling: Label Error on Declared StrengthJubilant Draximage Inc · D-0812-2016Class IIITerminatedApr 13, 2016Minocycline Hydrochloride Capsules USPLabeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of...Apace KY LLC · D-0811-2016Class IIITerminatedApr 13, 2016IntermezzoFailed Dissolution SpecificationsPurdue Pharma L.P. · D-0810-2016Class IIITerminatedApr 13, 2016Ranitidine SyrupFailed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.Bio-pharm, Inc. · D-0809-2016Class IITerminatedApr 13, 2016Formula 2Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0808-2016Class IITerminatedApr 13, 2016Formula 0Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0807-2016Class IITerminatedApr 13, 2016Formula 3Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0806-2016Class IITerminatedApr 13, 2016Formula 1Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.Meditech Laboratories, Inc · D-0805-2016Class IITerminatedApr 13, 2016Formula 9Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0804-2016Class IITerminatedApr 13, 2016Formula 4Lack of Assurance of Sterility: incomplete or missing data regarding production.Meditech Laboratories, Inc · D-0803-2016Class IITerminatedApr 13, 2016Formula 2Superpotent Drug: one ingredient was found to be above assay specification.Meditech Laboratories, Inc · D-0802-2016

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.